Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status

Evans, Denis A, David A Bennett, Robert S Wilson, Julia L Bienias, Martha Clare Morris, Paul A Scherr, Liesi E Hebert, Neelum Aggarwal, Laurel A Beckett, Rajiv Joglekar, Elizabeth Berry-Kravis and Julie Schneider

Arch Neurol. 2003. 60(2):185-9.

CONTEXT: Few studies compare Alzheimer disease (AD) incidence among black and white subjects. OBJECTIVE: To estimate incidence and the effect of the apolipoprotein E (APOE) epsilon4 allele in these races. DESIGN: Population-based study of disease incidence using a random, stratified sample. SETTING: A geographically defined community of 3 adjacent neighborhoods in Chicago, Ill. PARTICIPANTS: A total of 6158 persons 78.7% overall; 80.5% of the black subjects and 74.6% of the white subjects) participated; 4.1 years later, persons initially free of AD were sampled for clinical evaluation for disease incidence (overall 842 persons 74.8%] participated; 67.6% of the black subjects and 81.9% of the white subjects). INTERVENTIONS: None. MAIN OUTCOME MEASURE: Incident, clinically diagnosed AD. RESULTS: The effect of the APOE epsilon4 allele on the risk of AD differed strongly for black and white subjects. Among white subjects, the presence of the APOE epsilon4 allele was associated with a 2.73-fold (95% confidence interval [CI], 1.40-5.32) increase in risk while among black subjects there was no increase in risk (odds ratio, 1.02; 95% confidence interval, 0.39-2.68). Black race was associated with a nonsignificantly increased risk of AD with an odds ratio of 1.84 (95% CI, 0.73-4.66) if APOE and its interaction with race are considered, and an odds ratio of 1.28 (95% CI, 0.54-2.98) if they are not. The incidence of AD was 1.45% (95% CI, 0.89%-2.01%) per year among persons 65 to 74 years old, 4.73% (95% CI, 3.83%-5.64%) among those 75 to 84 years old, and 9.11% 95% CI, 7.36%-10.9%) among those 85 years and older. CONCLUSION: Apolipoprotein E epsilon4 led to increased risk of AD among white subjects but not black subjects.

Keywords: Aged; Aged, 80 and over; Alzheimer Disease/*epidemiology/ethnology/*genetics; Apolipoproteins E/*genetics; *Caucasoid Race; Epidemiologic Studies; Female; *Genetic Predisposition to Disease; Human; Incidence; Male; *Negroid Race; Risk Factors; Support, U.S. Gov't, P.H.S.; Urban Population



Close Window

UC Davis Health System is pleased to provide this information for general reference purposes only. It should not be considered as a substitute for professional medical advice. You are urged to consult with your health care provider for diagnosis of and treatment for any health-related condition. The information provided herein may not and should not be used for diagnosis and treatment.

Reproduction of material on this web site is hereby granted solely for personal use. No other use of this material is authorized without prior written approval of UC Regents.